Tag: Lirafit™
Glenmark becomes first to launch biosimilar of popular anti‐diabetic drug, Liraglutide,...
Lirafit™ will sharply lower the daily cost of therapy by around 70% to around Rs 100; making the drug more accessible to a larger number of patients with type 2 diabetes mellitus in the country